Russia eyes rollout of 1st mRNA melanoma vaccine in 2026-Xinhua

MOSCOW, Dec. 11 (Xinhua) — Russia’s first mRNA vaccine developed for melanoma therapy could be cleared for human use as early as 2026.

The Gamaleya National Research Center for Epidemiology and Microbiology has already produced several…